Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$2.25 USD
-0.35 (-13.46%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $2.25 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
FBIO 2.25 -0.35(-13.46%)
Will FBIO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for FBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FBIO
Here Is Why Bargain Hunters Would Love Fast-paced Mover Fortress Biotech (FBIO)
AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
FBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates
Myriad Genetics (MYGN) Reports Q2 Loss, Misses Revenue Estimates
Other News for FBIO
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
Fortress Biotech reduces total debt, enters $35M term loan
Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027
Fortress Biotech secures loan of up to $50M